These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8392005)

  • 1. An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator.
    Pyke C; Eriksen J; Solberg H; Nielsen BS; Kristensen P; Lund LR; Danø K
    FEBS Lett; 1993 Jul; 326(1-3):69-74. PubMed ID: 8392005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.
    Kristensen P; Eriksen J; Blasi F; Danø K
    J Cell Biol; 1991 Dec; 115(6):1763-71. PubMed ID: 1661735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.
    Ploug M; Eriksen J; Plesner T; Hansen NE; Danø K
    Eur J Biochem; 1992 Sep; 208(2):397-404. PubMed ID: 1325906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer.
    Luther T; Kotzsch M; Meye A; Langerholc T; Füssel S; Olbricht N; Albrecht S; Ockert D; Muehlenweg B; Friedrich K; Grosser M; Schmitt M; Baretton G; Magdolen V
    Thromb Haemost; 2003 Apr; 89(4):705-17. PubMed ID: 12669126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts.
    Rabbani SA; Rajwans N; Achbarou A; Murthy KK; Goltzman D
    FEBS Lett; 1994 Jan; 338(1):69-74. PubMed ID: 8307160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.
    Lund LR; Ellis V; Rønne E; Pyke C; Danø K
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):345-52. PubMed ID: 7646466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor.
    Montuori N; Salzano S; Rossi G; Ragno P
    FEBS Lett; 2000 Jul; 476(3):166-70. PubMed ID: 10913606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.
    Montuori N; Mattiello A; Mancini A; Santoli M; Taglialatela P; Caputi M; Rossi G; Ragno P
    FEBS Lett; 2001 Nov; 508(3):379-84. PubMed ID: 11728456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
    Roldan AL; Cubellis MV; Masucci MT; Behrendt N; Lund LR; Danø K; Appella E; Blasi F
    EMBO J; 1990 Feb; 9(2):467-74. PubMed ID: 1689240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells.
    Shetty S; Idell S
    Arch Biochem Biophys; 1998 Aug; 356(2):265-79. PubMed ID: 9705217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells.
    Stewart CE; Sayers I
    BMC Mol Biol; 2009 Jul; 10():75. PubMed ID: 19638192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
    Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
    Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
    Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
    Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction.
    Ploug M; Rahbek-Nielsen H; Ellis V; Roepstorff P; Danø K
    Biochemistry; 1995 Oct; 34(39):12524-34. PubMed ID: 7548000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.